{'output': [['FluoroPharma Medical Inc.', 'COMP', 'Announce', 'Completed buyback', 'EVENT'], ['FluoroPharma Medical Inc.', 'COMP', 'Operate_In', 'Biopharmaceutical Company', 'ORG'], ['FluoroPharma Medical Inc.', 'COMP', 'Control', 'CardioPET and BFPET', 'PRODUCT'], ['CardioPET and BFPET', 'PRODUCT', 'Licensed_From', 'Massachusetts General Hospital', 'ORG'], ['FluoroPharma Medical Inc.', 'COMP', 'Has', 'Two products in clinical trials', 'EVENT'], ['FluoroPharma Medical Inc.', 'COMP', 'Goal', 'Personalized medicine through precision diagnostics', 'CONCEPT'], ['FluoroPharma Medical Inc.', 'COMP', 'Has', 'Novel, proprietary PET imaging agents', 'PRODUCT'], ['FluoroPharma Medical Inc.', 'COMP', 'Patents_Issued_In', 'United States, Europe, China, Japan, Canada, Australia, Mexico', 'GPE'], ['FluoroPharma Medical Inc.', 'COMP', 'Focus', 'Development of breakthrough PET imaging agents', 'CONCEPT']]}